![Yi Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yi Liu
Oprichter bij Kumquat Biosciences, Inc.
Oorsprong van het eerstegraads netwerk van Yi Liu
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Intellikine LLC
![]() Intellikine LLC Pharmaceuticals: MajorHealth Technology Intellikine LLC develops and manufactures small molecule drugs for the treatment of cancer. The company focused on the development of potent, selective small molecule inhibitors of the PI3K/Akt/mTOR pathway for the treatment of cancer, inflammation and autoimmune disorders. Intellikine was founded on May 2nd, 2007 and is headquartered in La Jolla, CA.
13
| Extinct | Pharmaceuticals: Major | 13 |
Kumquat Biosciences, Inc.
![]() Kumquat Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Kumquat Biosciences, Inc. provides biotechnology services. The company was founded by Yi Liu and Pingda Ren and is headquartered in San Diego, CA.
5
| Private Company | Miscellaneous Commercial Services | 5 |
Wellspring Biosciences LLC
![]() Wellspring Biosciences LLC Pharmaceuticals: MajorHealth Technology Wellspring Biosciences LLC discovers and develops molecule drugs targeting signal transduction networks for the treatment of cancer and other diseases. The private company is based in La Jolla, CA. The company was founded by Pingda Ren.
3
| Private Company | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Yi Liu via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
KURA ONCOLOGY, INC. | Biotechnology | Director of Finance/CFO Founder Chief Executive Officer | |
AVIDITY BIOSCIENCES, INC. | Biotechnology | Director/Board Member Founder | |
Novartis Institute for Functional Genomics, Inc.
![]() Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Araxes Pharma LLC
![]() Araxes Pharma LLC Pharmaceuticals: MajorHealth Technology Araxes Pharma LLC develops drugs for the treatment of cancer and other diseases. The private company is based in La Jolla, CA. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Abintus Bio, Inc.
![]() Abintus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Abintus Bio, Inc. operates as a preclinical stage gene therapy company. It provides immune cell reprogramming services. The company was founded by John Snyder, Nicholas A. Boyle, Douglas J. Jolly, Carlos Ibañez, Derek Ostertag, and Cory Bentley and is headquartered in Encinitas, CA. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree | |
Frontier Medicines Corp.
![]() Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
I-MAB | Pharmaceuticals: Major | Chairman | |
Ysios Capital Partners SGEIC SA
![]() Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor | |
OLEMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
JIYA ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
F-STAR THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Pmk Bioresearch | Founder | ||
Anadys Pharmaceuticals, Inc.
![]() Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
Ona Therapeutics SL
![]() Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Ona Therapeutics SL is a biotech company based in Barcelona, Spain that specializes in discovering and developing therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. The Spanish company's focus is on developing novel therapies against advanced cancer. The company was founded in 2019 by Salvador Aznar Benitah and Valerie Liesbeth Brigitte Vanhooren, with Valerie Liesbeth Brigitte Vanhooren serving as CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Sardona Therapeutics, Inc. | Director/Board Member | ||
PATRYS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Proxenia Venture Partners LLC
![]() Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners LLC (Proxenia Venture Partners) is a venture capital firm founded in 2016 by Menghis Bairu. The firm is headquartered in wilmington, Delaware. | Investment Managers | Consultant / Advisor | |
The California State University | College/University | Doctorate Degree | |
REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Merck Serono Ltd.
![]() Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Max-Planck-Institute for Molecular Genetics | College/University | Doctorate Degree | |
F. Hoffmann-La Roche Ltd.
![]() F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BAYER AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Greifswald | College/University | Undergraduate Degree | |
Asklepios BioPharmaceutical, Inc.
![]() Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
StrideBio, Inc.
![]() StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | Biotechnology | Chief Executive Officer | |
Gilead Connecticut, Inc.
![]() Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Pharmaceuticals: Major | Founder | |
Yale University | College/University | Corporate Officer/Principal | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
Yale-New Haven Hospital, Inc.
![]() Yale-New Haven Hospital, Inc. Hospital/Nursing ManagementHealth Services Yale-New Haven Hospital, Inc. provides health care services and medical courses. The firm’s clinical programs and services include advanced vascular imaging services, allergy and immunology, ambulatory services, bariatric surgery program, cardiac rehabilitation, dental services, dermatology services, diabetes and endocrinology, ear, nose & throat (otolaryngology), electrophysiology and cardiac arrhythmia service and interventional cardiology. The company was founded in 1826 and is headquartered in New Haven, CT. | Hospital/Nursing Management | Corporate Officer/Principal | |
BioMarker Strategies LLC
![]() BioMarker Strategies LLC Pharmaceuticals: GenericHealth Technology BioMarker Strategies LLC develops medicines for cancer. It provides cancer diagnostics system for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. The company was founded by Scott Allocco, Kathleen Murphy and Douglas P. Clark in May 2006 and is headquartered in Rockville, MD. | Pharmaceuticals: Generic | Director/Board Member | |
G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
The Leukemia & Lymphoma Society, Inc.
![]() The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Turbine Hálózatelemzo Kutatási Fejlesztési Kft.
![]() Turbine Hálózatelemzo Kutatási Fejlesztési Kft. Packaged SoftwareTechnology Services Part of Turbine Simulated Cell Technologies Ltd., Turbine Hálózatelemzo Kutatási Fejlesztési Kft. The Hungarian company specializes in unlocking therapies with simulated cells™. Turbine computationally simulates tumor cell behavior in patients to understand the complex mechanisms driving the disease. The simulations can reveal the right modality and combination approach to treat even the most resistant cancers. The company's platform enables the simulation of drug-like effects from compounds that may not exist yet, on cells potentially unavailable for lab-based testing, like those of high unmet need cancer patients. is a Budapest-based company founded in 2013 by Daniel Veres, Szabolcs Nagy, and Kristof Zsolt Szalay. Szabolcs Nagy has been the CEO since 2013. | Packaged Software | Chairman | |
BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
IMMvention Therapeutix, Inc.
![]() IMMvention Therapeutix, Inc. BiotechnologyHealth Technology IMMvention Therapeutix, Inc. is an American biotechnology company that develops therapies. The company was founded by Jenny Ting and the CEO is Anil K. Goyal. | Biotechnology | Director/Board Member | |
Turbine Simulated Cell Technologies Ltd.
![]() Turbine Simulated Cell Technologies Ltd. Information Technology ServicesTechnology Services Turbine Simulated Cell Technologies Ltd. is a British company that leverages AI technology to understand oncology patients with simulated cells. The company is based in London, UK. and has subsidiaries in Hungary. The company was founded in 2019 by Szabolcs Nagy, Ivan Fekete, Daniel Veres, Kristof Zsolt Szalay. Szabolcs Nagy has been the CEO since 2019. | Information Technology Services | Chairman | |
Stritch School of Medicine | College/University | Doctorate Degree | |
Myeloid Therapeutics, Inc.
![]() Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Corporate Officer/Principal | |
eFFECTOR Therapeutics Operations, Inc.
![]() eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Founder | |
REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Founder | |
Mitokinin, Inc.
![]() Mitokinin, Inc. BiotechnologyHealth Technology Mitokinin, Inc. develops kinase neo-substrates for the treatment of neurodegenerative and mitochondrial diseases. The company was founded by Kevan Shokat, Nicholas Hertz, and Daniel de Roulet Jr. and is headquartered in New York, NY. | Biotechnology | Founder | |
EFFECTOR THERAPEUTICS, INC. | Biotechnology | Founder |
Statistieken
Internationaal
Verenigde Staten | 39 |
Verenigd Koninkrijk | 4 |
Duitsland | 4 |
Spanje | 3 |
Australië | 2 |
Sectoraal
Health Technology | 29 |
Consumer Services | 8 |
Commercial Services | 6 |
Finance | 5 |
Technology Services | 3 |
Operationeel
Director/Board Member | 116 |
Corporate Officer/Principal | 47 |
Independent Dir/Board Member | 35 |
Founder | 20 |
Chief Tech/Sci/R&D Officer | 17 |
Sterkste connecties
Insiders | |
---|---|
Carl Gordon | 59 |
Heidi Henson | 20 |
Pamela Klein | 19 |
William R. Rohn | 17 |
Gregory Berk | 17 |
Michael Martin | 17 |
Troy Wilson | 17 |
Mark Velleca | 14 |
Christian Rommel | 11 |
Paul F. Resnick | 10 |
Scott Platshon | 9 |
Kevan Shokat | 8 |
Pingda Ren | 8 |
Edgar H. Ulm | 7 |
Lynn Yang | 2 |